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Introduction
Despite the success of current vaccines, there is an urgent 
need or requirement of adjuvants for vaccines against 
various infectious diseases (1,2). Recently, one of the ap-
proved adjuvants for human use i.e. alum, enhanced only 
humoral immune response and poorly elicited cell medi-
ated immunity (3). Currently many plant based immuno-
modulators, i.e., stimulatory or immunosuppressive com-
pounds or molecules, are reported or still in clinical trials 
and these plant based candidates tried to use as adjuvants 
against specific protein antigen (4,5). In other words, plant 
based immunomodulators are under evaluation as newer 
and safer adjuvants (4,5). In view of credibility of plant-
based adjuvants with numerous supporting and related 
immunological bioactivities, it seems worthwhile that the 
directional approach may help grant potential protection 
to immune system in combination with vaccines. One of 
the most familiar examples of plant based adjuvants i.e., 
QS21 from Quillaja saponaria, showed significant im-
munomodulatory activity (6,7). The ability of plant-based 
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Introduction: Search for new adjuvants for human vaccines has become an expanding field of 
research in the last thirty years for generating stronger vaccines, capable of inducing protective 
and long lasting immunity in humans. The objective of this study was to investigate the 
immunoadjuvant activity of aqueous extract from the leaves of Calamus rotang using phosphate 
buffered saline (PBS, pH 7.2) against hepatitis B vaccine containing surface antigen (HBsAg; 20 
µg/mL). 
Methods: In this research qualitative study was evaluated in order to determine the presence of 
secondary metabolites and further confirmation of these metabolites through high performance 
thin layer chromatography (HPTLC) and identification by liquid chromatography mass 
spectrometry (LC-MS). In addition, indirect Elisa was performed using HBsAg as coating antigen 
and this aqueous extract showed anti-HBsAg titre at higher doses as compared to standard and 
control. In continuation of these studies, Swiss mice were immunized subcutaneously on day 
0 with HBsAg (20 µg/mL, 100 µL) and collect splenocytes on day 4 for splenocyte proliferation 
assay (ex vivo studies; again exposed with HBsAg) and estimation of Th1 (IFN-gamma and tumor 
necrosis factor [TNF-α]) cytokines from cell culture supernatant. 
Results: The aqueous leaves extract of C. rotang showed dose dependent enhancement in antibody 
titre and proliferation at higher doses (P < 0.01) with respect to HBsAg. In addition, this aqueous 
extract also showed improvement in Th1 (IFN-gamma and TNF alpha) cytokines at higher doses 
(P < 0.01) from cell culture supernatant as compared to standard HBsAg. 
Conclusion: Calamus rotang has additive adjuvant activity against hepatitis B vaccine antigen 
containing alum and may help to raise antibodies against HBsAg under challenging administration 
regimen and might be a potent vaccine adjuvant. 
A R T I C L E  I N F O
Keywords:
Calamus rotang
Hepatitis B vaccine
Antigen
Adjuvant
Proliferation
Cytokines
Article History:
Received: 6 March 2016
Accepted: 29 October 2016
Article Type:
Original Article
A B S T R A C T
Gupta A et al
Journal of Herbmed Pharmacology, Volume 6, Number 1, January 2017 http://www.herbmedpharmacol.com 44
vaccine adjuvant to deliver sufficient antigen to induce 
protective immune responses is now well established for 
a wide range of antigens. Today’s development of novel 
vaccines stresses the need for plant-based adjuvants that 
are inexpensive, easily administered and capable of be-
ing stored and transported without refrigeration (8,9). 
Without these properties, developing countries find it 
difficult to adopt vaccination as the central strategy for 
preventing their most devastating diseases. A promising 
approach is the production of vaccines containing plant-
based adjuvants.
High performance thin layer chromatography (HPTLC) 
is a powerful method used for qualitative and quantitative 
analytical tasks. Applications of HPTLC such as identifi-
cation and quantitation of bioactive phyto-constituents, 
impurities, process optimization, monitoring and stan-
dardization have been demonstrated (10). It is also report-
ed to achieve excellent separation, validation of methods 
for herbal and botanical dietary supplements, nutraceu-
ticals, various traditional healthcare systems (western 
medicines, Ayurveda) (11). Likewise liquid chromatogra-
phy mass spectrometry (LC-MS) is believed to be the easi-
est, accurate and appropriate technique for phytochemi-
cal profiling. This system presents synergistic approach 
of good separation power of liquid chromatography with 
excellent identification capacity of mass spectrometry to 
identify various phytochemicals present in the aqueous 
extract. In order to achieve this objective, one of proposed 
adjuvant candidate i.e. aqueous leaves extract of Calamus 
rotang showed various immunopharmacological activities 
(12-14). In the present study, our group evaluated the im-
munoadjuvant activity of aqueous leaves extract of C. ro-
tang against hepatitis B surface antigen (HBsAg).
Materials and Methods
Plant material
Assemblage of fresh plant leaves of C. rotang were collect-
ed from Vidya Pratishthan’s garden in Baramati, Maha-
rashtra, India. In this study, 5 g of fresh plant leaves were 
taken separately, macerated in liquid nitrogen to prepare 
fine powder and then dissolved in phosphate-buffered sa-
line (PBS). Collect the supernatant in the form of filtrate 
after centrifugation and then proceed for the estimation of 
secondary metabolites (qualitatively/quantitatively) and 
tested for immunoadjuvant activity.
Qualitative estimation of secondary metabolites
In an effort to estimate the presence of secondary metabo-
lites in aqueous leaves extract qualitatively various tests 
were used for the presence of terpenoids, flavonoids, gly-
cosides and phenolics. Qualitatively, this aqueous extract 
showed the presence of terpenoids, flavonoids, glycosides 
and phenolics but no alkaloid. In addition, HPTLC analy-
sis was carried out for phenolics and glycosides as shown 
in Figure 1. For phenolics, leaves sample was extracted 
with 70% ethanol. The plant was extracted at 60oC, dried 
and dissolved in methanol. The mixture was centrifuged 
at 3000 rpm for 5 minutes. The supernatant was used for 
sample application. In case of glycosides, the leaves sam-
ple was extracted with 70% ethanol (25 mL). The extract 
was kept in rotary shaker (120 rpm) for 8 hours. Lead ac-
etate was added to the filtrate based on the volume and 
centrifuged at 5000 rpm for 10 minutes. The supernatant 
was further centrifuged by adding 6.3% Na2CO3 (3 mL) 
at 10 000 rpm for 10 minutes (approximately for 20 mL 
filtrate 3 mL of Na2CO3 was added). The retained super-
natant was dried, re-dissolved in chloroform and used for 
sample application.
LC-MS analysis and specification
All MS acquisitions were performed in the positive elec-
trospray ionization mode. The capillary voltage, cone 
voltage, fragmentor voltage were 4 kV, 45 V and 170 V, 
respectively. The gas temperature was set at 325°C. Data 
was acquired at scan rate of 3 Hz in mass range 100-100 
m/z. Further data was analysed with MassHunter qualita-
tive software and METLIN database. 
LC was performed using Agilent 1260 Binary LC System 
having column of Agilent Zorbax SB 18 RRHT column 
(100×2.1 mm, 1.8 µm) with flow rate - 0.3 mL/min, run 
time - 30 minutes, injection vol -1 μL and MS at 6540 
ultra-high definition accurate mass QTOF LC/MS sys-
tem using mobile phase A:Water (0.1% formic acid) and 
mobile phase B: Acetonitrile. The LC gradient conditions 
were 95% of A and 5% of B for initial 5 to 18 minutes, 
then 5% of A and 95% of B for 18 to 27.10 minutes, and 
then 95% of A and 5% of B for final 27.10 to 30 minutes. 
Acquisition mode for MS with minimum range (m/z) was 
50 and maximum range (m/z) was 1700 whereas scanning 
rate (spectra/second) was 2.00.
ELISA 
Indirect ELISA was performed for detecting immunoad-
juvant activity of aqueous leaves extract of C. rotang using 
standard HBsAg (1:1000 dilution) as coating antigen. For 
these studies, freshly prepared aqueous extract of variable 
Figure 1. Qualitative HPTLC analysis of Calamus rotang for phenolics and glycosides.
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doses (2.5–10 mg) were added whereas anti-HBsAg sam-
ple was used as standard for estimation of IgG antibody 
titre. Horse anti-serum was used as secondary antibody 
and optical density measured at 450 nm (15). 
Ex vivo studies (splenocyte proliferation assay)
Immunological studies were conducted under ethical 
guidelines of animal ethics committee with registration 
No. 1814/PO/ERE/S/15/CPCSEA.
For these studies, Swiss mice (n = 5; sex- female; weight 
18-22 g) were selected and immunized HBsAg (100 µL) 
subcutaneously on day 0 and day 4, splenocytes were iso-
lated aseptically from the abdominal cavity of mouse. In 
this assay, splenocytes (105 cells/well; 100 µL) were taken 
in 96 well plate (flat bottom tissue culture plate, Griener) 
in presence of HBsAg (20 µg/mL; 10 µL) for 48 hours in-
cubation (in carbon dioxide incubator) along with vari-
able doses of aqueous leaves extract of C. rotang in a final 
volume of 0.2 mL. 
After incubation, MTT (2.5 mg/mL; 10 µL) solution was 
added in 96 well plates and again incubated for another 
3-4 hours. Thereafter, centrifuging the plate, the superna-
tant (for estimation of cytokines i.e., IFN-gamma and tu-
mor necrosis factor [TNF-α]) was collected and formazon 
crystals settled at the bottom were dissolved in dimethyl 
sulphoxide and the optical density was measured at 570 
nm (5,16).
Splenocyte cell culture supernatant containing HBsAg 
along with variable doses of aqueous leaves extract were 
collected after 48 hours incubation for the estimation of 
Th1 (IFN-gamma and TNF alpha) cytokines and perform-
ing Sandwich ELISA. This experiment was performed as 
per the manufacturer’s instructions (BD Biosciences) 
(5,16). 
Statistical analysis
The difference between control and treated groups (aque-
ous leaves extract) of C. rotang was determined by one-
way analysis of variance (ANOVA) test (Boniferroni mul-
tiple comparison test).
Results
LC-MS analysis
The aqueous extract of C. rotang was subjected to LC-
MS analysis and compounds were characterized based 
on their mass spectra, using the precursor ion, fragment 
ions, and comparison of the fragmentation patterns with 
molecules described in the literature. The analysis iden-
tified the presence of various bioactive phytochemicals 
such as Gentamicin C1a with retention time (rt) 07.00-
07.16 minutes and (M+H)+ ion at m/z 432. Netilmicin is 
an antibiotic of aminoglycoside family showing antibacte-
rial property against wide variety of bacteria. It was eluted 
at 7.26-7.39 minutes on LC column and (M+H)+ ion at 
m/z 476. Dipyridamole is well known to inhibit blood clot 
formation, having rt 8.35-8.73 minutes and (M+H)+ ion at 
m/z 487. Arbekacin is an aminoglycoside family antibiotic 
which shows antimicrobial activity against not only gram 
positive but also gram negative bacteria. Arbekacin had 
rt 8.53-8.77 minutes and (M+H)+ ion at m/z 553. Arte-
mether, an antimalarial drug is also identified by LC-MS 
having rt 14.34-14.49 with (M+H)+ ion at m/z 281. There 
were many other bioactive phytoconstituents which were 
identified using LC-MS, representative of which is shown 
in Figure 2.
ELISA
ELISA (indirect) results confirmed the immunoadjuvant 
activity of aqueous leaves extract of C. rotang against HB-
sAg vaccine and showed titre at higher doses as shown in 
Figure 3.
Splenocyte proliferation assay (ex vivo studies)
The effect of aqueous leaves extract of C. rotang on spleno-
cyte proliferation assay in Swiss mice (already immunized 
with HBsAg on day 0 subcutaneously) model studies as 
shown in Figure 4. The results showed that aqueous leaves 
extract showed enhancement in proliferation with respect 
to HBsAg (challenging dose given) at higher doses. HB-
sAg vaccine used as standard and showed enhancement in 
proliferation as compared to control.
Th1 cytokines
The effect of aqueous extract on Th1 (IFN-gamma and 
TNF alpha) cytokines from splenocyte cell culture super-
natant is shown in Figure 5. The results showed that aque-
ous extract enhanced the Th1 cytokines at higher doses 
as compared to control. In comparison with these two 
cytokines after estimating from splencoyte cell culture, 
the IFN-gamma was more effective and released in higher 
quantity as compared to TNF alpha in aqueous leaves ex-
tract of C. rotang.
Discussion
The development of plant based adjuvant for vaccine an-
tigens are essential for treating various infectious diseases. 
However, most of the adjuvants are failed to elicit cell me-
diated immunity during product development. This study 
was an effort to search for those adjuvant candidates i.e., 
plant based that are responsible for inducing both hu-
moral and cell mediated immune responses. In general, 
alum is one of the approved adjuvant for human use and is 
found in numerous vaccines e.g., HBsAg but it provoked 
only humoral response and poorly elicited cell mediated 
immunity. Recently, MF59, another adjuvant (emulsion 
based) was approved which is potent enhancer of both 
humoral and cell mediated immune responses. In 2015, 
Food and Drug Administration (FDA) approved a triva-
lent vaccine called as Fluad (formulated with MF59; ef-
fective for 65 years or more), produced from three strains 
of influenza (2 subtype A and 1 type B) for prevention of 
seasonal influenza. Now, only two adjuvants are approved 
i.e., alum and MF59. So, a number of scientists and re-
searchers have focused only on selective medicinal plant 
products especially leaves of C. rotang and tried to use as 
adjuvant against specific protein antigen. In this study, a 
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number of metabolites especially secondary in the form 
of terpenoids, flavonoids, phenolics, saponins, glycosides 
etc. were reported in aqueous extract. A lot of researches 
have already done related to various immunopharmaco-
logical studies. Out of these secondary metabolites, sapo-
nins (e.g., QS21 and its derivatives) and glycosides (e.g., 
RLJ-NE-299A) are used as adjuvant for vaccines and/or 
are still under investigation (5,7). 
For these studies, indirect ELISA was performed using 
variable doses of aqueous leaves extract against HBsAg 
and estimated whole IgG titre. The aqueous extract at 
higher doses showed enhancement in IgG titre as com-
pared to control. In this experiment, color development 
was directly proportional to the amount of antibody (IgG) 
and aqueous extract at higher doses showed higher color 
development. Finally, this assay i.e., indirect ELISA clearly 
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Fig.1. Qualitative HPTLC analysis of Calamus rotang for phenolics and glycosides. 
 
 
Fig.2. MS spectra for representative bioactive phytochemicals identified in Calamus 
rotang. 
 
 
Figure 2. MS spectra for representative bioactive phytochemicals identified in Calamus rotang.
Figure 3. ELISA assay. Indirect ELISA was performed using standard 
HBsAg (1:1000 dilution) as coating antigen. Aqueous leaves extract were 
used for the estimation of anti-HBsAg antibody titre. Horse anti-serum 
used as secondary antibody and optical density measured at 450 nm. 
The difference between the control versus standard and aqueous extract 
were determined by one-way ANOVA test. * P < 0.05 and ** P < 0.01 versus 
control.
Figure 4. Effect of aqueous leaves extract of Calamus rotang on splenocyte 
proliferation assay. Spleen cells (106 cells/mL; 100 µL) were treated with 
variable doses of aqueous leaves extract in presence HBsAg (as already 
described in materials and methods section). Values are expressed 
in mean ± SE. The difference between the control versus standard and 
aqueous extract were determined by one-way ANOVA test. * P < 0.05 and 
** P < 0.01 versus control.
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indicated the enhancement in IgG titre at higher doses in 
aqueous leaves extract of C. rotang against HBsAg.
Another experiment was performed using HBsAg and de-
termined splenocyte proliferation assay in animal model 
ex vivo using Swiss mice. For these studies, mice were im-
munized on day 0 with HBsAg and the splenocytes were 
collected on day 4 and determined the proliferation. The 
aqueous leaves extract of C. rotang showed enhancement 
in proliferation at higher doses as compared to control. In 
other words, HBsAg were exposed to splenic lymphocytes 
in presence of aqueous leaves extract. The results were 
dose dependent change in the proliferation as compared 
to HBsAg and control. Normally, HBsAg was recognized 
strongly by aqueous leaves extract of C. rotang containing 
primary as well as secondary metabolites and antibody-
secreting cells from vaccines. Finally, there was good cor-
relation between the aqueous leaves extract of C. rotang 
as vaccine adjuvant candidate and the conventional vac-
cine antigen which were tested by ELISA and proliferation 
assays.
Although IFN-gamma and TNF-α have been reported 
involved in antiviral immune responses, also they play 
an important role in T-cell proliferation, natural killer 
(NK) cell activation, and cytokine induction. Although 
Th1 cells secrete IFN-gamma, they activate macrophages 
and induce cell-mediated immunity which protect against 
intracellular pathogens (invasive bacteria, protozoa and 
viruses) (5,16). Interestingly, this study has linked the 
adjuvant activities of aqueous leaves extract of C. rotang 
against HBsAg. In this study, we evaluated immunoadju-
vant activity of aqueous extract. It could be determined 
through cytokines (IFN-gamma and TNF-α) from splen-
coyte cell culture supernatant whether these aqueous ex-
tracts show stimulatory or suppressive effect. The aqueous 
extract showed enhancement in Th1 cytokines at higher 
doses as compared to HBsAg and control. Overall, the 
aqueous leaves extract of C. rotang showed vaccine adju-
vant potential, but it is urgently needed some preserva-
tives to store for long time in clinical trial studies. 
Conclusion 
The aqueous extract of C. rotang has immunoadjuvant 
activity against HBsAg and this aqueous extract has en-
hancement effect on IgG titre along with proliferation 
(splenocyte) and Th1 cytokines from cell culture super-
natant. Overall, the aqueous extract of C. rotang also has 
enhancement effect on IgG titre and cell mediated im-
mune response. Next study is recommended to emphasize 
on aqueous leaves extract and its safety, potency including 
toxicity. Also, clinical trials for the development of effec-
tive adjuvants that will help facilitate effective next-gener-
ation vaccines against devastating infectious diseases are 
recommended.
Authors’ contributions
All the authors designed the study, wrote the protocol 
and interpreted the data. AG anchored the field study, 
gathered the initial data and performed preliminary data 
analysis whereas ACS for HPTLC and LC-MS analysis. All 
the authors managed the literature searches and produced 
the initial draft. All authors read and approved the final 
manuscript.
Conflict of interests
Authors have declared that no conflict of interest exist.
Ethical considerations 
These studies were conducted under ethical guidelines 
with registration no. 1814/PO/ERE/S/15/CPCSEA
Funding/Support
This research was financially supported by Vidya Pratish-
than’s School of Biotechnology (in house project).
References
1. Allison AC, Byars NE. Immunological adjuvants: desirable 
properties and side-effects. Mol Immunol. 1991;28:279. 
2. Marrack P, McKee AS and Munks MW. Towards an 
understanding of the adjuvant action of aluminium. Nat 
 
0
10
20
30
40
50
60
IFN-gamma  TNF alpha
pg
/m
l  
(M
ea
n 
±
S.
E.
)
Control HBsAg 2.5 mg/ml 5 mg/ml 10 mg/ml
**
*
***** *
Figure 5. Effect of aqueous leaves extract of Calamus rotang on Th1 cytokines. Spleen cells (106 cells/mL; 100 µL) were treated with 
variable doses of aqueous leaves extract in presence HBsAg and cell culture supernatant was collected for the estimation of cytokines 
(IFN-gamma and TNF alpha). Values are expressed in Mean ± SE. The difference between the control versus standard and aqueous 
extract were determined by one-way ANOVA test. * P < 0.05 and ** P < 0.01 versus control.
Gupta A et al
Journal of Herbmed Pharmacology, Volume 6, Number 1, January 2017 http://www.herbmedpharmacol.com 48
Rev Immunol. 2009;9(4):287-93.
3. Roels LG. Unmet needs in modern vaccinology adjuvants to 
improve the immune response. Vaccine. 2010;28(S3):C25–3.
4. Khajuria A, Gupta A, Malik F, et al. A new vaccine adjuvant 
(BOS 2000) a potent enhancer mixed Th1/Th2 immune 
responses in mice immunized with HBsAg. Vaccine. 
2007;25(23):4586-94. 
5. Khajuria A, Gupta A, Singh S, et al. RLJ-NE-299A: a new 
plant based vaccine adjuvant. Vaccine. 2007;25(14):2706-
15.
6. Jacobsen NE, Fairbrother WJ, Kensil CR, Lim A, Wheeler 
DA, Powell MF. Structure of the saponin adjuvant QS-21 
and its base-catalyzed isomerization product by 1H and 
natural abundance 13C NMR spectroscopy. Carbohydr 
Res. 1996;280:1–14.
7. Kensil CR, Kammer R. QS-21: a water-soluble triterpene 
glycoside adjuvant. Exp Opin Investig Drugs. 1998;7:1475– 
82.
8. Gupta KR, Relyveld EH, Lindblad EB, et al. Adjuvants: 
a balance between toxicity and adjuvanticity. Vaccine. 
1993;11:293-306.
9. Hu S, Concha C, Lin F, Persson WK. Adjuvant effect of 
Ginseng extracts on the immune response to immunization 
against Staphylococcus aureus in dairy cattle. Vet Immunol 
Immunopathol. 2003;91:29–37.
10. Patel RB, Patel MR, Patel BG. Experimental aspects and 
implementation of HPTLC. In: Srivastava MM, ed. High 
performance thin layer chromatography (HPTLC). Berlin 
Heidelberg: Springer;2011:41-54. 
11. Sharma J. Modern thin layer chromatography. J AOAC Int. 
2008;91:1142-4.
12. Gupta A, Chaphalkar SR. Assessment of Immunomodulatory 
activity of aqueous extract of Calamus rotang. Avicenna J 
Phytomed. 2016;5(2):1-7.
13. Gupta A, Chaphalkar SR. Immunosuppressive activity of 
crude saponins from the leaves of Calotropis gigantean, 
Calamus rotang and Artocarpus integrifolia. Int J Pharm Sci 
Res. 2015;5(7):1-5. 
14. Gupta A, Chaphalkar SR. Rapid detection of 
immunosuppressive activity of aqueous extract of Calamus 
rotang using flow cytometry. J Med Chem Drug Discov. 
2015;2:1-8.
15. Gupta A, Chaphalkar SR. Immunoadjuvant potential 
of Azadirachta indica against rabies, hepatitis and DPT 
vaccine antigen. Int J Med Pharm Sci. 2015;5(7):1–5.
16. Gupta A, Khajuria A, Singh J, et al. Immunomodulatory 
activity of biopolymeric fraction RLJ-NE-205 from 
Picrorhiza kurroa. Int Immunopharmacol. 2006;6(10):1543-
9.
